Mammoth Biosciences, Inc. — Form D

Mammoth Biosciences, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-23. The offering totals $13.2M, of which $13.2M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2018-08-23
• Form: D
• Accession: 0001750963-18-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $13.2M
• Amount sold: $13.2M
• Investors: 28
• Date of first sale: 2018-05-15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-319929

Issuer

• Name: Mammoth Biosciences, Inc.
• CIK: 0001750963
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2017
• Address: 953 INDIANA STREET, SAN FRANCISCO, CA, 94107
• Phone: 770-655-1937

Officers, directors & promoters (7)

Other filings by this issuer (1)

More

• CIK 1750963 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search